Significant strategic progress in delivering our 2025 priorities: Continued to lead with the application of innovative ...
Mesoblast shares (ASX:MSB) closed sharply lower on Friday despite reporting a sixteen-fold revenue increase, as markets digested mixed signals about the biotech's commercial momentum and path to ...
The shareholders of Heimstaden AB (publ), reg.no. 556670-0455 (the “ Company ”), are hereby summoned to the annual general meeting on Friday, 27 March 2026, at 10:00 a.m. CET. The annual general ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results